Skip to content

NOTICIERO VOIDVOID TERMINAL

AI Web3 Crypto Stocks Finance Macro Prediction Markets Technology Markets Newsletter

PRO

Front page › Markets

Markets

Oppenheimer reiterates Outperform on UroGen Pharma stock at $60

Investing.com28 Oct 2026, 11:20 UTC

Read the full story at Investing.com

Related

Logitech's $130 PT defended by Wedbush after stock slump post-earnings Seeking Alpha
Top Managed Health Care Stock Pick From BofA Research Investing.com
Lynx sees SK Hynix results rekindling interest in this chip stock Investing.com
Scotiabank raises SoFi stock price target to $26 on strong results Investing.com
Scotiabank cuts Colliers stock price target on 2026 guidance risk Investing.com
Compass Point lowers Galaxy Digital stock price target on discount rate Investing.com
Robinhood now makes more money from predicting the future than trading crypto CryptoSlate
Moody's Rates Ripple's $2.6B RLUSD Stablecoin A2, a Day After OCC Bank Approval Decrypt

Economy & Central Banks · AI · Markets · Crypto · Web3 · Stocks · Technology · Finance · Commodities · Currencies · Geopolitics · All news · About · Editorial policy · Privacy

NOTICIERO VOID ·

Economy · Markets · Crypto · Commodities · Currencies · Geopolitics · About · Editorial policy · Privacy · RSS

Data: FRED (St. Louis Fed), U.S. Treasury FiscalData, Federal Reserve, ECB, BEA, CoinGecko, DefiLlama, GeckoTerminal, OKX, Solana RPC and publisher RSS feeds. Headlines link to the original publishers. Keyboard: g then t/m/n/c to jump · / search.